Status of current clinical trials in diabetic polyneuropathy

被引:11
作者
Bril, V [1 ]
机构
[1] Univ Toronto, UHN, Toronto Gen Hosp, Toronto, ON M5G 2C4, Canada
关键词
D O I
10.1017/S0317167100001335
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Peripheral polyneuropathy is the most frequent complication of diabetic mellitus. In spite of many clinical trials of different specific interventions for diabetic polyneuropathy, intensive glycemic control remains the only effective specific therapy currently available for this troublesome complication. This systematic overview reports the status of current clinical trials in diabetic polyneuropathy with an emphasis on those interventions directed towards specific pathophysiological derangements. A discussion of clinical trials of agents directed towards relieving painful symptoms of diabetic polyneuropathy concludes this overview.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 92 条
[41]   Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy [J].
Harati, Y ;
Gooch, C ;
Swenson, M ;
Edelman, S ;
Greene, D ;
Raskin, P ;
Donofrio, P ;
Cornblath, D ;
Sachdeo, R ;
Siu, CO ;
Kamin, M .
NEUROLOGY, 1998, 50 (06) :1842-1846
[42]   Diabetes and the nervous system [J].
Harati, Y .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (02) :325-+
[43]   Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy [J].
Harati, Y ;
Gooch, C ;
Swenson, M ;
Edelman, SV ;
Greene, D ;
Raskin, P ;
Donofrio, P ;
Cornblath, D ;
Olson, WH ;
Kamin, M .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2000, 14 (02) :65-70
[44]   ANTIHYPOXIC TREATMENT AT AN EARLY STAGE OF DIABETIC NEUROPATHY - AN ELECTROPHYSIOLOGICAL STUDY WITH SABELUZOLE [J].
HENDRIKSEN, PH ;
OEY, PL ;
WIENEKE, GH ;
BANGA, JD ;
VANDAM, PS .
ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (05) :506-511
[45]   Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: Multicenter study (Reprinted from Excerpta Medica International Congress, series 1084, 1995) [J].
Hotta, N ;
Sakamoto, N ;
Shigeta, Y ;
Kikkawa, R ;
Goto, Y .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1996, 10 (03) :168-172
[46]   Mexiletine - A review of its therapeutic use in painful diabetic neuropathy [J].
Jarvis, B ;
Coukell, AJ .
DRUGS, 1998, 56 (04) :691-707
[47]   TREATMENT OF CHRONIC PAINFUL DIABETIC NEUROPATHY WITH INTRAVENOUS LIDOCAINE INFUSION [J].
KASTRUP, J ;
ANGELO, HR ;
PETERSEN, P ;
DEJGARD, A ;
HILSTED, J .
BRITISH MEDICAL JOURNAL, 1986, 292 (6514) :173-173
[48]   TREATMENT OF DIABETIC NEUROPATHY WITH GAMMA-LINOLENIC ACID [J].
KEEN, H ;
PAYAN, J ;
ALLAWI, J ;
WALKER, J ;
JAMAL, GA ;
WEIR, AI ;
HENDERSON, LM ;
BISSESSAR, EA ;
WATKINS, PJ ;
SAMPSON, M ;
GALE, EAM ;
SCARPELLO, J ;
BODDIE, HG ;
HARDY, KJ ;
THOMAS, PK ;
MISRA, P ;
HALONEN, JP .
DIABETES CARE, 1993, 16 (01) :8-15
[49]   Venlafaxine HCI in the treatment of painful peripheral diabetic neuropathy [J].
Kiayias, JA ;
Vlachou, ED ;
Lakka-Papadodima, E .
DIABETES CARE, 2000, 23 (05) :699-699
[50]   IMIPRAMINE TREATMENT OF PAINFUL DIABETIC NEUROPATHY [J].
KVINESDAL, B ;
MOLIN, J ;
FROLAND, A ;
GRAM, LF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (13) :1727-1730